Evidence map›Paper›PMID 30209756›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020

Viability assessment by

Eigo Kurebayashi, Osamu Manabe, Masanao Naya, Shiro Miura, Takehiro Yamashita, Yoshihiro Imai, Akira Ando, Chihoko Miyazaki, Toshihisa Anzai

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Stress myocardial perfusion gated-SPECT imaging in advanced chronic kidney disease.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eigo KurebayashiHokkaido Ohno Memorial Hospital, Sapporo, Japan.
Osamu ManabeDepartment of Nuclear Medicine, Hokkaido University of Graduate School of Medicine, Sapporo, Japan.
Masanao NayaDepartment of Cardiovascular Medicine, Hokkaido, University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan. naya@med.hokudai.ac.jp.
Shiro MiuraHokkaido Ohno Memorial Hospital, Sapporo, Japan.
Takehiro YamashitaHokkaido Ohno Memorial Hospital, Sapporo, Japan.
Yoshihiro ImaiHokkaido Ohno Memorial Hospital, Sapporo, Japan.
Akira AndoHokkaido Ohno Memorial Hospital, Sapporo, Japan.
Chihoko MiyazakiHokkaido Ohno Memorial Hospital, Sapporo, Japan.
Toshihisa AnzaiDepartment of Cardiovascular Medicine, Hokkaido, University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
Cardiovascular Center Hokkaido Ohno Hospital · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Positron Emission Tomography Computed TomographyAged, 80 and overCoronary AngiographyCoronary Artery DiseaseEchocardiographyFluorodeoxyglucose F18Heart AneurysmHumansMalePredictive Value of TestsRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID30209756
OpenAlexW2891113615

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.